Follow the people · Insider

HV

Hannah Valantine

Insider · Director · CDNA

Hannah Valantine files insider transactions with the SEC as a director of CareDx (CDNA). We hold 6 disclosed purchases and sales filed since 21 June 2021, 4 of them in the last 90 days.

  • Files forCDNA
  • Disclosed buys and sells6 in all, 4 in the last 90 days
  • Last disclosure17 July 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 1 July 202116 July 2026Director · CareDx (CDNA)25 Form 4 lines · source: SEC Form 4
  • Filed 25 October 202123 June 2026Director · BridgeBio Pharma (BBIO)59 Form 4 lines · source: SEC Form 4
  • Filed 16 June 20213 June 2026Director · Pacific Biosciences Of California (PACB)7 Form 4 lines · source: SEC Form 4

Everything they disclosed

91 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.